HSBC Holdings’s Radiopharm Theranostics RADX Stock Holding History
Bought
Maintained
Sold
Other funds holding RADX
HSBC Holdings's RADX Position: Q3 2026 in Review
HSBC Holdings reduced its Radiopharm Theranostics (RADX) stake by 64% in Q3 2026, selling an estimated $111K and leaving 22,483 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.
HSBC Holdings first reported a position in RADX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.01M in Q4 2025. 8 funds tracked by Wall St. Rank hold RADX as of Q3 2026.
- HSBC Holdings held 22,483 shares of Radiopharm Theranostics worth $33.9K as of Q3 2026.
- HSBC Holdings sold 39,705 Radiopharm Theranostics shares in Q3 2026, an estimated $111K.
- Radiopharm Theranostics made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2846 holding.
- HSBC Holdings first reported a position in Radiopharm Theranostics in Q4 2025 and has held it in 4 quarters since.
- HSBC Holdings's Radiopharm Theranostics position peaked at $1.01M in Q4 2025.
- 8 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.